Search Within

Marc Rosenblum

  1. "Benjamin Durham"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Department of Pathology and Laboratory Medicine (10)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Executive Committee, Center for Hematologic Malignancies (7)
  6. GSK Faculty (7)

More Groups

People
  1. Benjamin Durham (10)
  2. Eli Diamond (9)
  3. Omar Abdel-Wahab (7)
  4. Ahmet Dogan (6)
  5. Kseniya Petrova-Drus (6)
  6. Mariko Yabe (6)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2020 (1)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Modern Pathology (2)
  2. Pediatric Blood and Cancer (2)
  3. British Journal of Haematology (1)
  4. Clinical Cancer Research (1)
  5. Journal of Clinical Oncology (1)
  6. Laboratory Investigation (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. Nature Research (2)
  3. Wiley Periodicals, Inc (2)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. John Wiley & Sons (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neurologic and oncologic features of Erdheim-Chester disease: A 30-patient series
    Journal Article

    Bhatia, A.; Hatzoglou, V.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Yabe, M.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • The histopathology of Erdheim-Chester disease: A comprehensive review of a molecularly characterized cohort
    Journal Article

    Ozkaya, N.; Rosenblum, M. K.; Durham, B. H.; Pichardo, J. D.; Abdel-Wahab, O.; Hameed, M. R.; Busam, K. J.; Travis, W. D.; Diamond, E. L.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
    Journal Article

    Mass, E.; Jacome-Galarza, C. E.; Blank, T.; Lazarov, T.; Durham, B. H.; Ozkaya, N.; Pastore, A.; Schwabenland, M.; Chung, Y. R.; Rosenblum, M. K.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • Clinicopathologic features of Erdheim-Chester disease (ECD): A histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/ERK pathway
    Meeting Abstract

    Ozkaya, N.; Durham, B. H.; Park, C.; Rosenblum, M.; Diamond, E.; Dogan, A.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Clinicopathologic features of Erdheim-Chester disease (ECD): A histiocytic neoplasm characterized by deregulation of RAS/RAF/MEK/ERK pathway
    Meeting Abstract

    Ozkaya, N.; Durham, B. H.; Park, C.; Rosenblum, M.; Diamond, E.; Dogan, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save